Bariatric surgery outperforms traditional treatments for long-term diabetes control

Bariatric surgery proves superior to medical and lifestyle management in long-term glycemic control and diabetes remission for T2DM patients, highlighting its viability as a treatment option.

Post-Hoc: RFK vs. Vivek, and the future of US drug policy

President-elect Donald Trump has just set up a showdown for the future of biopharma policy during his administration. On one side is Trump’s pick to

November 16, 2024

Cybin Announces Grant of Two New United States Patents Protecting its Deuterated DMT Program | Psychedelic Finance

Cybin Inc. (NYSE American:CYBN) (NEO:CYBN) (“Cybin” or the “Company”), a clinical-stage biopharmaceutical company committed to revolutionizing mental healthcare by developing new and innovative psychedelic-based treatment

October 28, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.

Bariatric surgery outperforms traditional treatments for long-term diabetes control

Post-Hoc: RFK vs. Vivek, and the future of US drug policy

Cybin Announces Grant of Two New United States Patents Protecting its Deuterated DMT Program | Psychedelic Finance

At stake in mifepristone case: Abortion, FDA’s authority, and return to 1873 obscenity law

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

Subscribe